AFP and hepatocellular carcinoma: With the increasing burden of HCC, it is vital to identify novel biomarkers with enhanced sensitivity and specificity in addition to alpha fetoprotein (AFP), including circRNA, to guide the diagnosis and systemic treatment of HCC (104).